Showing results (341-350 of 3,904) with videos related to
Sort By:
Pageof 391
American Journal of Cancer Research|October 5, 2011
Epigenetic reprogramming of Myc target genesStefano Amente, Luigi Lania, Barbara MajelloAmerican Journal of Cancer Research|October 22, 2011
Menin represses tumorigenesis via repressing cell proliferationTing Wu, Xianxin HuaAmerican Journal of Cancer Research|October 22, 2011
Recurring mutations in myeloproliferative neoplasms alter epigenetic regulation of gene expressionGary W ReutherAmerican Journal of Cancer Research|October 22, 2011
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersGiulia Grisendi, Rita Bussolari, Elena Veronesi, et al.American Journal of Cancer Research|October 22, 2011
Base excision repair targets for cancer therapyGrigory L DianovAmerican Journal of Cancer Research|October 22, 2011
Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspectsMohammad A Shahshahan, Maureen N Beckley, Ali R JazirehiAmerican Journal of Cancer Research|November 9, 2016
Autophagy inhibition promotes epithelial-mesenchymal transition through ROS/HO-1 pathway in ovarian cancer cellsZhe Zhao, Jing Zhao, Jing Xue, et al.American Journal of Cancer Research|November 9, 2016
Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblastsDoudou Li, Chao Qu, Zhouyu Ning, et al.American Journal of Cancer Research|November 9, 2016
Downregulation of Semaphorin-3F is associated with poor prognostic significance in osteosarcoma patientsMing-Han Liu, Wen-Juan Fu, You-Hong Cui, et al.American Journal of Cancer Research|November 9, 2016
Hydroxyl-HIF2-alpha is potential therapeutic target for renal cell carcinomasTakahiro Isono, Tokuhiro Chano, Tetsuya Yoshida, et al.Pageof 391